STAGE I BREAST CANCER AJCC V7
Clinical trials for STAGE I BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE I BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE I BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough breast cancer: drug cocktail targets resistant tumors
Disease control CompletedThis phase II trial tested a combination of panitumumab (a targeted therapy) plus two chemotherapy drugs (carboplatin and paclitaxel) given before surgery to women with triple-negative breast cancer that didn't respond to standard chemo. The goal was to shrink tumors and reduce t…
Matched conditions: STAGE I BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
Promising combo may keep breast cancer from returning
Disease control CompletedThis study tested a combination of two chemotherapy drugs (cyclophosphamide and paclitaxel) plus a targeted antibody (trastuzumab) given after surgery to 20 patients with early-stage HER2-positive breast cancer. The goal was to see if this treatment is safe and can prevent the ca…
Matched conditions: STAGE I BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Smart pill bottles and video visits boost cancer drug adherence
Disease control CompletedThis study tested whether using telehealth (video visits with a doctor) and smart pill bottles can help breast cancer patients take their hormone therapy more consistently. 305 women and men with early-stage hormone receptor-positive breast cancer participated. The goal was to se…
Matched conditions: STAGE I BREAST CANCER AJCC V7
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
New combo shrinks hard-to-treat breast tumors before surgery
Disease control CompletedThis study tested a combination of enzalutamide (a hormone blocker) and paclitaxel (chemotherapy) given before surgery to 24 people with a specific type of triple-negative breast cancer that has androgen receptors. The goal was to see if this treatment could shrink tumors enough …
Matched conditions: STAGE I BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC